Physician profile
Julia Caldwell
NPI 1215137500
$13,877.05
in general payments reported to CMS, 2019-2025
43 companies · $873 in 2025
The $873 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,400 · 2020: $3,041 · 2021: $2,212 · 2022: $2,218 · 2023: $1,612 · 2024: $521 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,751 · Travel and Lodging: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,751.21 |
| Travel and Lodging | $254.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $3,024.96 | 2019-2020 | |
| Medtronic, INC. | $1,951.75 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Boston Scientific Corporation | $970.98 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $909.69 | 2019-2021 | |
| Flowonix Medical Incorporated | $753.94 | 2019-2020 | |
| Nevro Corp. | $751.21 | 2019-2023 | Senza |
| Amgen INC. | $703.10 | 2019-2022 | |
| Abbvie INC. | $664.72 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Tersera Therapeutics LLC | $494.08 | 2019-2025 | Prialt |
| Grt US Holding, INC. | $304.72 | 2020-2022 | |
| Allergan, INC. | $297.47 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $285.06 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $244.46 | 2020-2024 | Relistor |
| Pfizer INC. | $228.43 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $213.66 | 2019-2024 | Ztlido |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $206.85 | 2019-2021 | |
| Lilly USA, LLC | $185.04 | 2019-2024 | Amyvid, Kisunla |
| Lundbeck LLC | $171.82 | 2021-2024 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $156.85 | 2022 | |
| Vertos Medical, INC. | $156.52 | 2022-2023 | Mild Device Kit |
| Globus Medical, INC. | $152.33 | 2025 | Senza |
| Teva Pharmaceuticals USA, INC. | $149.96 | 2019-2024 | Austedo Xr, Ajovy |
| Abbott Laboratories | $125.10 | 2022-2025 | Octrode, Eterna, Proclaim |
| Stimwave Technologies Incorporated | $80.87 | 2021 | |
| Saol Therapeutics INC. | $77.05 | 2019-2020 | |
| Ibsa Pharma INC. | $66.57 | 2021-2022 | |
| Mml US, INC. | $65.29 | 2023-2025 | Reactiv8 |
| Averitas Pharma INC. | $59.97 | 2023-2025 | Qutenza |
| Biohaven Pharmaceuticals, INC. | $52.38 | 2021 | |
| Axsome Therapeutics, INC. | $51.51 | 2025 | Symbravo |
| Vertex Pharmaceuticals Incorporated | $50.42 | 2025 | |
| Hikma Pharmaceuticals USA | $35.00 | 2022 | |
| Ani Pharmaceuticals, INC. | $33.55 | 2023 | Purified Cortrophin Gel |
| Kowa Pharmaceuticals America, INC. | $31.33 | 2023 | Seglentis |
| Collegium Pharmaceutical, INC. | $29.93 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $23.38 | 2019 | |
| Novo Nordisk INC | $21.28 | 2025 | Wegovy |
| Tonix Medicines, INC. | $20.96 | 2025 | Tonmya |
| Pacira Pharmaceuticals Incorporated | $20.73 | 2023 | Iovera, Zilretta, Exparel |
| Curonix LLC | $15.42 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Valinor Pharma, LLC | $14.67 | 2025 | Movantik |
| Horizon Therapeutics Plc | $12.94 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.